Reig Jofre, a Barcelona, Spain-headquarted pharmaceutical company, has created a joint venture with LeanBio, a biotechnology company, to develop biosimilar products and new molecules. The joint venture, Syna Therapeutics, will be owned 50/50 by the two companies.
Under the agreement, ReigOriginal Article
